Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
8.34
-0.01 (-0.12%)
Feb 6, 2026, 4:00 PM EST - Market closed
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $155.98 million as of February 9, 2026.
Market Cap
155.98M
Enterprise Value
80.52M
1-Year Change
n/a
Ranking
Category
Stock Price
$8.34
Market Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $155.98M, a decrease of -27.29%. That is a compound annual growth rate of -30.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 155.98M | -1.18% |
| Dec 31, 2025 | 157.85M | -26.42% |
| Mar 19, 2025 | 214.52M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tharimmune | 163.65M |
| Innate Pharma | 158.29M |
| ProQR Therapeutics | 158.02M |
| Compugen | 156.20M |
| Zentalis Pharmaceuticals | 154.75M |
| Sangamo Therapeutics | 148.67M |
| Century Therapeutics | 148.59M |
| Rani Therapeutics Holdings | 148.26M |